Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ruiz-Ortega, M.
Right arrow Articles by Egido, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruiz-Ortega, M.
Right arrow Articles by Egido, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 27-33
© 2001 European Renal Association-European Dialysis and Transplant Association

Angiotensin II activates nuclear transcription factor-{kappa}B in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice

Marta Ruiz-Ortega, Oscar Lorenzo, Mónica Rupérez, Yusuke Suzuki and Jesús Egido

Laboratory of Vascular and Renal Pathology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain

Background. Nuclear factor-{kappa}B (NF-{kappa}B) regulates many genes involved in vascular physiopathology. Angiotensin II (Ang II) participates in the pathogenesis of several cardiovascular diseases. In a model of atherosclerosis, we have noted NF-{kappa}B activation in the neointimia lesion that was decreased by angiotensin-converting enzyme (ACE) inhibitors. However, the potential direct effect of Ang II in the vascular activation of NF-{kappa}B has not been completely elucidated.

Methods. We first investigated whether Ang II elicited in vivo activation of NF-{kappa}B in large vessels of normal rats by systemic infusion of Ang II (50 ng/kg/min, s.c.) into rats for 72 h. In order to investigate the receptor involved in this process, we also studied the direct effect of Ang II on cultured vascular smooth muscle cells (VSMCs) from wild-type and AT1 knockout mice.

Results. Ang II-infused rats showed activated NF-{kappa}B in the endothelial and vascular smooth muscle cells of the aorta (southwestern histochemistry). In cultured VSMCs from wild-type mice, Ang II increased NF-{kappa}B activity that was partially inhibited by AT1 (losartan) and AT2 (PD123319) antagonists. In VSMC from AT1 knockout mice, Ang II also activated NF-{kappa}B.

Conclusions. These data show that Ang II via AT1 and AT2 activates NF-{kappa}B in vascular cells both in vivo and in vitro, and suggest a potential involvement of the AT2 receptor in the pathogenesis of vascular diseases, including hypertension and atherosclerosis.

Keywords: angiotensin II; AT1 knockout mice; NF-{kappa} B; vascular cells

Correspondence and offprint requests to: Marta Ruiz-Ortega, PhD, Laboratory of Renal and Vascular Pathology, Fundación Jiménez Díaz, Avda Reyes Católicos, 2, 28040 Madrid, Spain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
K. Pankow, Y. Wang, F. Gembardt, E. Krause, X. Sun, G. Krause, H.-P. Schultheiss, W.-E. Siems, and T. Walther
Successive Action of Meprin A and Neprilysin Catabolizes B-Type Natriuretic Peptide
Circ. Res., October 26, 2007; 101(9): 875 - 882.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Haurani and P. J. Pagano
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?
Cardiovasc Res, September 1, 2007; 75(4): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
V Teplitsky, Y Shoenfeld, and A Tanay
The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans
Lupus, June 1, 2006; 15(6): 319 - 325.
[Abstract] [PDF]


Home page
HypertensionHome page
A. A. Elmarakby, J. E. Quigley, D. M. Pollock, and J. D. Imig
Tumor Necrosis Factor {alpha} Blockade Increases Renal Cyp2c23 Expression and Slows the Progression of Renal Damage in Salt-Sensitive Hypertension
Hypertension, March 1, 2006; 47(3): 557 - 562.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
S Ewert, T Sjoberg, B Johansson, A Duvetorp, M Holm, and L Fandriks
Dynamic expression of the angiotensin II type 2 receptor and duodenal mucosal alkaline secretion in the Sprague-Dawley rat
Exp Physiol, January 1, 2006; 91(1): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Wu, M.-A. Laplante, and J. de Champlain
Cyclooxygenase-2 Inhibitors Attenuate Angiotensin II-Induced Oxidative Stress, Hypertension, and Cardiac Hypertrophy in Rats
Hypertension, June 1, 2005; 45(6): 1139 - 1144.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Farjah, T. L. Washington, B. P. Roxas, D. L. Geenen, and R. S. Danziger
Dietary NaCl Regulates Renal Aminopeptidase N: Relevance to Hypertension in the Dahl Rat
Hypertension, February 1, 2004; 43(2): 282 - 285.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Bataller, E. Gabele, R. Schoonhoven, T. Morris, M. Lehnert, L. Yang, D. A. Brenner, and R. A. Rippe
Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver
Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G642 - G651.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Wolf
The road not taken': role of angiotensin II type 2 receptor in pathophysiology
Nephrol. Dial. Transplant., February 1, 2002; 17(2): 195 - 198.
[Full Text] [PDF]


Home page
HypertensionHome page
S. A. Mezzano, M. Ruiz-Ortega, and J. Egido
Angiotensin II and Renal Fibrosis
Hypertension, September 1, 2001; 38(3): 635 - 638.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.